2m 2m 2m 2m 2m 2m 2m
Boston Scientifi (BSX)
NYSE
$45.35+$1.02 (+2.29%)
Price as of Jun 23, 2026 2:06 PM EDT- $65.9BMarket Cap
- -56.69%1-Year Change
- Medical DevicesIndustry
Boston Scientifi (BSX)
$45.35+$1.02 (+2.29%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 20.1B +19.87% | 16.7B +17.61% | 14.2B +12.29% | 12.7B +6.68% | |
Cost of Revenue | 6.2B +18.34% | 5.3B +20.99% | 4.3B +9.83% | 4.0B +6.60% | |
Gross Profit | 13.9B +20.57% | 11.5B +16.11% | 9.9B +13.40% | 8.7B +6.73% | |
Sales and Marketing Expense | 6.9B +15.09% | 6.0B +15.30% | 5.2B +14.82% | 4.5B +3.69% | |
Research and Development Expense | -2.1B +27.06% | -1.6B +14.21% | -1.4B +6.88% | -1.3B +9.88% | |
Depreciation and Amortization Expense | 1.4B +7.80% | 1.3B +6.10% | 1.2B +5.28% | 1.1B +3.93% | |
Total Operating Expenses | 10.2B +15.24% | 8.9B +17.66% | 7.6B +6.71% | 7.1B +1.43% | |
Operating Profit | 3.6B +38.80% | 2.6B +11.10% | 2.3B +42.09% | 1.6B +37.53% | |
Interest Income | 139.0M +275.95% | -79.0M +33.90% | -59.0M +5,800.00% | -1.0M -100.40% | |
Interest Expense | -349.0M +14.43% | -305.0M +15.09% | -265.0M -43.62% | -470.0M +37.83% | |
Interest Income and Expense and Net | -210.0M -45.31% | -384.0M +18.52% | -324.0M -31.21% | -471.0M +417.58% | |
Total Nonoperating Income and Expense | 349.0M +14.43% | 305.0M +427.96% | -93.0M +144.74% | -38.0M -117.43% | |
Income before Taxes | 3.4B +48.33% | 2.3B +14.96% | 2.0B +73.97% | 1.1B +6.04% | |
Income Taxes | 493.0M +13.07% | 436.0M +10.94% | 393.0M -11.29% | 443.0M +1,130.56% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 2.9B +56.66% | 1.8B +15.95% | 1.6B +128.08% | 698.0M -32.95% | |
Net Income from Continuing Operations Applicable to Common | 2.9B +56.40% | 1.9B +18.03% | 1.6B +144.55% | 642.0M -34.82% | |
Basic EPS and Net Income | 1.96 +55.56% | 1.26 +16.67% | 1.08 +140.00% | 0.45 -34.78% | |
Diluted EPS and Net Income | 1.94 +55.20% | 1.25 +16.82% | 1.07 +137.78% | 0.45 -34.78% | |
Basic Weighted Average Shares | 1.5B +0.60% | 1.5B +1.27% | 1.5B +1.57% | 1.4B +0.58% | |
Diluted Weighted Average Shares | 1.5B +0.58% | 1.5B +1.53% | 1.5B +1.65% | 1.4B +0.41% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.0B +374.64% | 414.0M -52.14% | 865.0M -6.79% | 928.0M -51.79% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 2.0B +374.64% | 414.0M -52.14% | 865.0M -6.79% | 928.0M -51.79% | |
Total Current Assets | 8.8B +27.08% | 6.9B +6.23% | 6.5B +13.09% | 5.8B -8.82% | |
Accumulated Depreciation | 3.6B +2.18% | 3.5B +1.41% | 3.5B +6.15% | 3.3B +0.27% | |
Property and Plant and Equipment and Net | 4.0B +22.53% | 3.3B +15.22% | 2.9B +16.88% | 2.4B +8.61% | |
Total Long-Term Assets | 1.9B +6.39% | 1.8B +14.57% | 1.5B +2.07% | 1.5B +6.38% | |
Total Assets | 43.7B +10.86% | 39.4B +12.12% | 35.1B +8.21% | 32.5B +0.74% | |
Income Taxes Payable | 220.0M +41.94% | 155.0M +15.67% | 134.0M -6.94% | 144.0M -53.55% | |
Total Short-Term Debt | 299.0M -83.18% | 1.8B +234.84% | 531.0M +2,555.00% | 20.0M -92.34% | |
Total Current Liabilities | 5.4B -15.00% | 6.4B +29.72% | 4.9B +29.71% | 3.8B -11.02% | |
Total Long-Term Debt | 11.1B +24.19% | 9.0B +4.63% | 8.6B -3.86% | 8.9B +1.26% | |
Total Long-Term Liabilities | 2.4B +28.61% | 1.9B -4.93% | 2.0B -3.34% | 2.0B -8.33% | |
Total Liabilities | 5.4B -15.00% | 6.4B +29.72% | 4.9B +29.71% | 3.8B -11.02% | |
Retained Earnings | 5.6B +108.42% | 2.7B +226.37% | 819.0M +209.20% | -750.0M -46.12% | |
Total Stockholders Equity | 24.2B +11.31% | 21.8B +12.90% | 19.3B +9.73% | 17.6B +5.72% | |
Total Shares Outstanding | 1.7B +0.49% | 1.7B +0.51% | 1.7B +1.91% | 1.7B +0.46% | |
Cash Flow | |||||
Cash from Operating Activities | 4.5B +31.99% | 3.4B +37.24% | 2.5B +64.02% | 1.5B -18.40% | |
Capital Expenditures | 876.0M +10.89% | 790.0M +11.11% | 711.0M +20.92% | 588.0M +6.14% | |
Cash from Investing Activities | -2.6B -53.58% | -5.7B +120.94% | -2.6B +28.00% | -2.0B +25.92% | |
Dividends Paid | N/A N/A | 0 -100.00% | 28.0M -49.09% | 55.0M 0.00% | |
Cash from Financing Activities | -395.0M -121.78% | 1.8B +36,180.00% | 5.0M +100.91% | -548.0M +476.84% | |
Financials Ratio | |||||
Gross Margin | 69.01% +0.58% | 68.61% -1.26% | 69.49% +0.99% | 68.81% +0.03% | |
Operating Margin | 18.00% +15.80% | 15.54% -5.53% | 16.45% +26.54% | 13.00% +28.92% | |
Return on Assets | 6.96% +40.56% | 4.95% +5.18% | 4.71% +118.27% | 2.16% -34.70% | |
Return on Equity | 12.57% +39.80% | 8.99% +4.10% | 8.64% +111.62% | 4.08% -37.35% | |
Revenue Growth | 19.87% +12.84% | 17.61% +43.31% | 12.29% +83.94% | 6.68% -66.48% | |
Current Ratio | 1.62 +49.51% | 1.08 -18.11% | 1.32 -12.82% | 1.51 +2.48% | |
Cash Ratio | 0.36 +458.42% | 0.06 -63.09% | 0.18 -28.16% | 0.24 -45.83% | |
Debt-to-Equity Ratio | 0.47 -4.40% | 0.49 +4.58% | 0.47 -7.18% | 0.51 -6.77% | |
Debt-to-Assets Ratio | 0.26 -4.00% | 0.27 +5.29% | 0.26 -5.85% | 0.28 -2.17% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow